ZB
AMPH icon

Zions Bancorporation’s Amphastar Pharmaceuticals AMPH Stock Holding History

Zions Bancorporation’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-59
Closed -$2K – 924
2022
Q2 		$2K Sell
59
-21
-26% -$749 ﹤0.01% 960
2022
Q1 		$3K Buy
+80
New +$2.27K ﹤0.01% 1011

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Zions Bancorporation's AMPH Position: Q3 2022 in Review

Zions Bancorporation sold out of Amphastar Pharmaceuticals (AMPH) in Q3 2022, closing a stake of 59 shares — an estimated $2K sold.

Zions Bancorporation first reported a position in AMPH in Q1 2022 and held it in 2 quarters. The position peaked at $3K in Q1 2022. 205 funds tracked by Wall St. Rank hold AMPH as of Q3 2022.

  • Zions Bancorporation reported no remaining Amphastar Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Zions Bancorporation sold 59 Amphastar Pharmaceuticals shares in Q3 2022, an estimated $2K.
  • Zions Bancorporation first reported a position in Amphastar Pharmaceuticals in Q1 2022 and held it in 2 quarters.
  • Zions Bancorporation's Amphastar Pharmaceuticals position peaked at $3K in Q1 2022.
  • 205 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2022.

Based on Zions Bancorporation's 13F filing for Q3 2022, filed 8 Nov 2022.